An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency
Clinical trial NCT03845712 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03845712
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-05
- Primary completion
- 2026-08-14
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.